The LITESPARK-022 study tested belzutifan, an oral small-molecule inhibitor of hypoxia-inducible factor-2α (HIF-2α) targeting angiogenesis, in combination with standard of care pembrolizumab as ...
1 Department of Pediatrics, Faculty of Health Sciences and Technologies, Gamal Abdel Nasser University, Conakry, Republic of Guinea. 2 Pediatric Emergency, CHU Donka, Ministry of Higher Education, ...
People with progressive kidney failure may suffer from medical emergencies such as critically high potassium levels or severe ...
Dear Anon.: The answer is one to two years for a person with a GFR of 10 who doesn't receive kidney replacement therapy, like ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results